Friday, May 03, 2024 | Last Update : 09:52 AM IST
Ibalizumab
New HIV drug cuts viral load, boosts immunity: Study
Ibalizumab is a drug that targets the primary receptor for HIV entry into immune cells known as CD4 T cells.
16 Aug 2018 6:37 PM
1 of 1
ADVERTISEMENT
ADVERTISEMENT
more
Columns
Political discourse swirls around the dilemma of wealth tax policy in India
Chief Minister's minimalist approach leaves key commissions vacant
Critique of exam-centric education system urges for reforms to preserve childhood and promote holistic learning
Amid Foreign Policy Successes, China's Assertiveness Remains Conspicuously Absent from Political Discourse